Additive manufacturing or 3D printing is witnessing innovations left, right and center. In various industries such as education, manufacturing, engineering, and medical, the use is extensive. It is pertinent to note here that it is the printing of biomaterials such as cells, components etc. in three dimension and that while it is a new area, it has made notable advancement in the past few years.
It is important to note here that basis the kind of material, approach of bioprinting changes. It also changes according to cell types, cell growth factors, and other complexities relating to living tissues. This happens because there is a need for process to be sensitive to differences in these cells.
The domain of 3D bioprinting comes into play in a number of disciplines. Some of these include cell biology, physics, biomaterial sciences, and engineering. And, this process can also be use by experts in these fields and researchers so a wide variety of tissue can be developed. Designing and sizing of bones, vascular grafts, multi-layered skin, cartilaginous structure, tracheal splints, and cardiac tissue. As 3D bioprinting is used widely in this field, market for the same will chart significant growth.
Thus, it does not come as a surprise that as per a comprehensive market report brought out by Transparency Market Research (TMR), the global 3D bioprinting market is on a high growth trajectory over the forecast period of 2017 and 2025. The repost carries incisive insights on market dynamics and unravels trends and drivers that are shaping the landscape of the market over the coming years. Besides, it gives a peek into regional growth potential – share, and opportunities, etc.
Demand or high throughput models of tissue, used extensively in drug research and discovery processes, is all set to propel growth in the global bioprinting market. And, since pharmaceutical and biotechnology market are coextensive with 3D bioprinting, development in the former leads to growth in the latter. Here, it is worth noting that advanced drug screening is also adding to the growth curve of the global 3D bioprinting market in a positive manner.
Additionally, extensive use in regenerative therapies which includes transplantation and generation will also underpin notable growth in the market. And, the advancements in regenerative medicine is also supporting this growth curve over the forecast period.
The global 3D bioprinting market is fragmented and key players in the landscape include TeVido BioDevices, Rainbow Biosciences, 3D Systems, Inc., regenHU, EnvisionTEC GmbH, Stratasys Ltd., nScrypt, Inc., Regenovo Biotechnology Co., GeSiM, and Aspect Biosystems Ltd. These are profiled in the report and provide insight into strategies deployed by each to maintain a prominent hold over the global 3D bioprinting market.
The regional analysis of the report is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Europe and North America will account for a prominent share of the global bioprinting market. There is a high demand for 3D printing in advanced clinical applications in the region. It is important to talk here of the upscaling of research and development in biotechnology and pharmaceutical industry in a number of North American and European countries.
Interested in this report?
Get a FREE Brochure now!
*Get Brochure (PDF) sent to your email within minutes
Complete the form below and we'll get back to you shortly.